Myelomonocytic Leukemia
📧 Sign up to get email alerts when something new happens for Myelomonocytic Leukemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2018-03-19Clinical Trial Update: Relevance of Peripheral Cells in the Pathophysiology of Chronic Myelomonocytic Leukemia (CMML)
This document provides an update on the relevance of peripheral cells in the pathophysiology of Chronic Myelomonocytic Leukemia (CMML).
-
CLINICAL_TRIALS research · 2017-03-03Clinical Trial Update: Comparison Between Cyclophosphamide and Combination of Methotrexate + Calcineurin Inhibitor for GVHD Prophylaxis [Phase 3]
A Phase 3 trial comparing cyclophosphamide with methotrexate plus a calcineurin inhibitor for GVHD prophylaxis in patients with various hema…
-
CLINICAL_TRIALS research · 2016-05-19Clinical Trial Update: Biomarkers in Bone Marrow Samples From Pediatric Patients With High-Risk Acute Myeloid Leukemia
A completed pediatric AML biomarker study update from the Children's Oncology Group examining biomarkers in bone marrow from high-risk AML p…
-
CLINICAL_TRIALS research · 2015-04-24Clinical Trial Update: A Study of the Efficacy and Safety of Lenalidomide Combined to Escalating Doses of Chemotherapy in Intermediate-2-or High Risk Myelodysplastic Syndrome (MDS) and Acute Myeloid Leukemia (AML) With Del 5q [Phase 2]
This is a Phase 2 clinical trial evaluating lenalidomide combined with escalating-dose chemotherapy for intermediate-2 or high-risk myelodys…
-
CLINICAL_TRIALS research · 2010-09-03Clinical Trial Update: Use of Decitabine in Myelodysplastic Syndrome (MDS) Following Azacitidine (AZA) Failure [Phase 2]
Phase 2 clinical trial exploring decitabine for myelodysplastic syndrome after azacitidine failure.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.